Podcast: Spin-Offs and Acquisitions in the Pharmaceutical Industry Vicki Tauscher Phelan and Rich Pierle discuss operational outsourcing contract considerations for spin-offs and acquisitions. Recorded:  Nov 2009   Features:    Vicki Tauscher Phelan, EquaTerra Pharmaceutical Managing Director, and                        Rich Pierle, Client Executive, EquaTerra                     Duration:     approximately 15.5 minutes Discussion Highlights: What the increase in spin-offs means for outsourcing buyers What companies should consider when evaluating divestitures/spin-offs What to think about to operationalize strategy Service provider community interest in divestitures, spin-offs, etc. Click here to listen to the podcast now.   More from EquaTerra on Outsourcing in the Pharmaceutical Industry: Emerging BPO & KPO Trends in the Pharmaceutical Industry Bigger, Broader and Better Linked: Considerations for Integrated Sourcing of Facilities Management and Real Estate Pharmacovigilance and Clinical Data Management Theory of Natural Selection: The Role of the Sourcing Advisor Evolves Case Study:  Pharmaceutical Spin-Off Transitions IT from Parent Company Charting a Future Course for Outsourcing in the Pharmaceutical Industry